ANI Pharmaceuticals Inc (ANIP)
NASDAQ:ANIP
Holding ANIP?
Track your performance easily

ANI Pharmaceuticals (ANIP) Financial Statements

284 Followers

ANI Pharmaceuticals Financial Overview

ANI Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $1.223; its P/E ratio is 50.24; ANI Pharmaceuticals is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $1.42. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 138.04M$ 137.43M$ -38.78M$ 131.83M$ 116.55M
Gross Profit$ 80.34M$ 88.27M$ -49.47M$ 83.73M$ 74.26M
EBIT$ 2.37M$ 29.93M$ -76.07M$ 17.91M$ 13.35M
EBITDA$ 17.07M$ 44.62M$ -61.02M$ 33.12M$ 28.04M
Net Income Common Stockholders$ -2.69M$ 17.80M$ -78.78M$ 9.53M$ 5.84M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 240.11M$ 228.60M$ 221.12M$ 193.08M$ 161.71M
Total Assets$ 920.75M$ 914.52M$ 1.02B$ 889.91M$ 859.34M
Total Debt$ 285.24M$ 285.46M$ 284.82M$ 285.88M$ 286.09M
Net Debt$ 45.13M$ 56.86M$ 63.70M$ 92.80M$ 124.39M
Total Liabilities$ 440.14M$ 437.71M$ 421.99M$ 435.20M$ 424.87M
Stockholders Equity$ 480.61M$ 476.81M$ 442.83M$ 454.71M$ 434.47M
Cash Flow-
Free Cash Flow$ 12.96M$ 27.20M$ 42.77M$ 27.62M$ 13.80M
Operating Cash Flow$ 17.41M$ 18.27M$ 44.74M$ 32.17M$ 20.63M
Investing Cash Flow$ -4.45M$ 8.93M$ -4.78M$ -4.55M$ -6.83M
Financing Cash Flow$ -1.45M$ -19.73M$ -11.92M$ 3.75M$ 80.15M
Currency in USD

ANI Pharmaceuticals Earnings and Revenue History

ANI Pharmaceuticals Debt to Assets

ANI Pharmaceuticals Cash Flow

ANI Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis